EXTENTRAK Trademark

Trademark Overview


On Tuesday, September 19, 2017, a trademark application was filed for EXTENTRAK with the United States Patent and Trademark Office. The USPTO has given the EXTENTRAK trademark a serial number of 87614116. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 4, 2019. This trademark is owned by Loxo Oncology, Inc.. The EXTENTRAK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; therapeutic pharmaceutical for the treatment of cancer, autoimmune disease and immunologic-based disease; full line of pharmaceutical preparations for cancer, autoimmune disease and immunologic-based disease
extentrak

General Information


Serial Number87614116
Word MarkEXTENTRAK
Filing DateTuesday, September 19, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 4, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; therapeutic pharmaceutical for the treatment of cancer, autoimmune disease and immunologic-based disease; full line of pharmaceutical preparations for cancer, autoimmune disease and immunologic-based disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 25, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLoxo Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressStamford, CT 06901

Party NameLoxo Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStamford, CT 06901

Trademark Events


Event DateEvent Description
Monday, November 4, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 4, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 26, 2019EXTENSION 2 GRANTED
Tuesday, February 26, 2019EXTENSION 2 FILED
Tuesday, February 26, 2019TEAS EXTENSION RECEIVED
Saturday, September 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 13, 2018EXTENSION 1 GRANTED
Thursday, September 13, 2018EXTENSION 1 FILED
Thursday, September 13, 2018TEAS EXTENSION RECEIVED
Tuesday, April 3, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 22, 2017ASSIGNED TO EXAMINER
Monday, September 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 22, 2017NEW APPLICATION ENTERED IN TRAM